Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

Oncologist - United States
doi 10.1634/theoncologist.2015-0114
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Algorithm for the Treatment of Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer: An Evidence-Based Overview

Current Oncology
Oncology
2018English

P1.01-043 Molecular Testing for Non-Small Cell Lung Cancer in Latin American

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Importance of Molecular Features of Non–Small Cell Lung Cancer for Choice of Treatment

American Journal of Pathology
Forensic MedicinePathology
2011English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

The Treatment Choice Based on Radiographic Features for Metastatic Brain Tumors in ALK-Rearranged Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy